Literature DB >> 2613486

The course of renal amyloidosis with uraemia.

B Lindqvist1, S Andersen, B Isacsson, E Lundberg.   

Abstract

The course of uraemia in 47 patients with renal amyloidosis has been studied. The median survival with a S-creatinine of 150 mumol/l was approximately 18 months, but 15% survived for more than 3 years. Deterioration arose often suddenly and was of unclear cause. Approximately 25% of the patients improved for a while and the reason for this temporary improvement is also unclear. The unsteady course during the uraemia period for amyloidosis patients makes prognosis calculations very much less accurate than for patients with cystic kidneys.

Entities:  

Mesh:

Year:  1989        PMID: 2613486     DOI: 10.1007/bf02549595

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  3 in total

1.  Ten years' experience of an amyloid clinic--a clinicopathological survey.

Authors:  M J Browning; R A Banks; C R Tribe; P Hollingworth; C Kingswood; J C Mackenzie; P A Bacon
Journal:  Q J Med       Date:  1985-03

2.  Presentation and course of primary amyloidosis of the kidney.

Authors:  C S Ogg; J S Cameron; D G Williams; D R Turner
Journal:  Clin Nephrol       Date:  1981-01       Impact factor: 0.975

3.  Prognosis curves for patients with polycystic kidney disease.

Authors:  S Andersen; B Lindqvist; L Nyström
Journal:  Ann Clin Res       Date:  1982-04
  3 in total
  1 in total

1.  Outcome of 121 patients with renal amyloid a amyloidosis.

Authors:  Elbis Ahbap; Ekrem Kara; Tuncay Sahutoglu; Taner Basturk; Yener Koc; Tamer Sakaci; Mustafa Sevinc; Cuneyt Akgol; Zuhal Atan Ucar; Arzu Ozdemir Kayalar; Feyza Bayraktar; Ayse Aysim Ozagari; Abdulkadir Unsal
Journal:  J Res Med Sci       Date:  2014-07       Impact factor: 1.852

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.